Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire made its biggest ever acquisition yet in January 2015 with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals. The move came a few months after the group's sale to rival AbbVie collapsed.
Financial Data
-
31st Dec 16 Source: CRO
- €1.6 billion turnover
-
€115.2 million
profit - 109 employees
-
31st Dec 15 Source: CRO
- €1.1 billion turnover
-
€68.6 million
profit - 100 employees
- 8 more years available »
Ranking
By Turnover
(€1.6 billion)- 56th in Top Companies
- 10th in Pharma
By Employees
(109)- 691st in Top Companies
- 65th in Pharma
-
- 109
- €1.6 billion
Employees
- Flemming Ornskov CEO/Managing Director
Latest News
- 8:34am Brexit uncertainty ‘prevents surge’ in UK economy
- 8:04am Barclays chief to keep job despite move to unmask whistle-blower
- 7:53am House of Fraser looks at restructuring to cut costs
- 7:39am Kingspan reports ‘sluggish start’ to year due to weather
- 7:22am Bank of Ireland looks to keep ‘tight control’ of costs